Implantable bottom exit port

Information

  • Patent Grant
  • 8715158
  • Patent Number
    8,715,158
  • Date Filed
    Friday, February 4, 2011
    13 years ago
  • Date Issued
    Tuesday, May 6, 2014
    10 years ago
Abstract
The present invention provides a system for attaching a fluid access port to a patient. The system generally comprises an implantable access port with a bottom exit port and method for attaching an access port to a patient. In addition, a tube guard, flexible tube exit port, tissue guard, and porous coupling member are disclosed.
Description
FIELD

The present invention generally relates to medical systems and apparatus and uses thereof for treating obesity or obesity-related diseases, and more specifically, relates to access ports and methods for applying the same to bodily tissue.


BACKGROUND

Adjustable gastric banding apparatus have provided an effective and substantially less invasive alternative to gastric bypass surgery and other conventional surgical weight loss procedures. Despite the positive outcomes of invasive weight loss procedures, such as gastric bypass surgery, it has been recognized that sustained weight loss can be achieved through a laparoscopically-placed gastric band, for example, the LAP-BAND® (Allergan, Inc., Irvine, Calif.) gastric band or the LAP-BAND AP® (Allergan, Inc., Irvine, Calif.) gastric band. Generally, gastric bands are placed about the cardia, or upper portion, of a patient's stomach forming a stoma that restricts food's passage into a lower portion of the stomach. When the stoma is of an appropriate size that is restricted by a gastric band, the food held in the upper portion of the stomach may provide a feeling of satiety or fullness that discourages overeating. Unlike gastric bypass procedures, gastric band apparatus are reversible and require no permanent modification to the gastrointestinal tract.


Medical implants, including gastric band systems, for performing therapeutic functions for a patient are well known. Such devices include pace makers, vascular access ports, injection ports (such as used with gastric banding systems) and gastric pacing devices. Such implants need to be attached, typically subcutaneously, in an appropriate place in order to function properly.


Many implantable medical devices are secured with sutures. For example, when inserting a gastric band and an associated access port, the associated access port may be sutured into place with sutures against the rectus muscle sheath. Such placement of the sutures is often challenging because the associated access port is placed below several inches of bodily tissue (e.g., fat), and suturing the associated access port often takes as long as placing the gastric band itself.


Additionally, the sutures can cause post surgical pain for the patient due to the inherent pulling and slight tearing of the tissue pieces by and adjacent to the suture.


Also, it is common for medical professionals desiring to add or remove fluid via a needle through the access port to palpitate the skin to locate the implanted port. The medical professional has a general idea of the top surface of the port, but occasionally will accidentally miss the septum and puncture the tube and/or tissue surrounding or adjacent to the port.


Further, some body-related systems utilize retention geometry for the access port attachment such as Bestetti, et al., U.S. Pat. No. 6,270,475. However, Bestetti discloses a percutaneous access port not a subcutaneous access port. Similarly, Svensson, et al., U.S. Pat. No. 5,098,397, discloses a percutaneous access port not a subcutaneous access port.


Accordingly, there remains a need for a procedure to implant medical devices in a quick, easy and efficient manner, utilizing as small of an incision as possible which reduces the likelihood of future discomfort for the patient and protects the elements from errant needle strikes.


SUMMARY

The present invention, in one embodiment, includes an implantable fluid access port of an adjustable gastric banding system coupled to the tissue of a patient. The port is configured to facilitate fluid transfer to and from the gastric banding system. The device includes a top housing section including a top opening, a septum surface, a bottom exit tube coupling, and a bottom housing section with a substantially circular side wall. A partial interior vessel may be formed between the fluid seal created between the bottom surface of the septum and the interior surfaces of the bottom housing portion.


In some embodiments, the implantable port may be configured to shield a coupled tube from inadvertent needle puncture using at least one of the orientation of the bottom exit tube coupling, needle entry orientation, or the structures of the body of the implantable port. The bottom exit tube coupling may be configured to provide a partial anchoring of the implantable port in a pre-selected position.


The device may include a porous coupling member having a top surface and a bottom surface. The porous coupling member may be integral to the implantable fluid access port or coupled to the implantable fluid access port via a coupling agent proximate to the top surface of the porous coupling member for mating with the base of the implantable access port. The porous coupling member may extend in a plane substantially parallel to the base of the bottom housing section and may be configured for anchoring the port to the tissue of the patient. The porous coupling member may be made from injection moldable plastic or rubber. The porous coupling member may be formed as a partial ring shape or a substantially circular shape. The porous coupling member may extend in a plane substantially parallel to the base of the port, including a first portion (proximate to the implantable access port) and a second portion. The first portion may not include a porous surface and the second portion may include a porous surface. The surface that does not include a porous surface may be configured to shield a portion of the patient from contact with a needle.


The implantable fluid access port may further include a guard plate configured to shield the bottom exit tube coupling and/or a tube from contact with a needle. The guard plate may include channels or openings configured to allow fluid to pass from the partial interior vessel to the bottom exit tube coupling. The guard plate may be internal to the partial interior vessel. The bottom housing section may include surface features for positioning a guard plate and/or channeling fluid from the partial interior vessel to the bottom exit tube coupling.


In one embodiment, the bottom exit tube coupling may further include a ball joint socket structure and/or coupling technique. In this embodiment, the bottom exit tube coupling may include a boot.


In some embodiments, the bottom exit tube coupling may be made from a silicon rubber material. The top housing section and the bottom housing section may couple together to place the septum surface under compression. The top housing section and the bottom housing section may be securably coupled together via locking tabs.


In some embodiments, the implantable fluid access port may further include a mesh material oriented between the implantable access port and a coupling member. A through hole in the mesh material may be configured to allow the coupler to pass through the through hole to mate with the base of the implantable access port. This way, the mesh may be sandwichably held in position. The mesh material may be a pre-fabricated mesh material made from injection moldable plastic or rubber. The port may be implanted subcutaneously.


In one embodiment, a method of securably coupling an implantable fluid access port of an adjustable gastric banding system configured to facilitate fluid transfer to and from the gastric banding system is disclosed. The method may include subcutaneously coupling an implantable fluid access port having a bottom exit tube coupling to the tissue of a patient, and coupling the tube of an adjustable gastric banding system to the bottom exit tube coupling.


The method may include protecting the bottom exit tube coupling via a guard plate internal to the port. In some embodiments, the bottom exit tube coupling is made from a silicon rubber material. The port may include a septum configured to receive a needle for fluid transfer. The subcutaneous coupling may be performed via a mesh material oriented between the implantable access port and a coupling member, sutures, and/or using a porous coupler.


These and other aspects and embodiments of the present invention may be more clearly understood or appreciated by referring to the accompanying drawings and the detailed description.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A illustrates a gastric band port according to an embodiment of the present invention.



FIG. 1B illustrates the gastric band port of FIG. 1A and a coupling device according to an embodiment of the present invention.



FIG. 1C illustrates the gastric band port of FIGS. 1A and 1B and the coupling device of FIG. 1B secured to the tissue of a patient according to an embodiment of the present invention.



FIG. 1D illustrates an exploded view of the components of the port of FIG. 1A according to an embodiment of the present invention.



FIG. 1E illustrates a perspective view of a port and a bottom exit extended tube coupling mated with a tube extension according to an embodiment of the present invention.



FIG. 1F illustrates a side cut-away view of the port and the bottom exit extended tube coupling of FIG. 1E according to an embodiment of the present invention.



FIG. 2A illustrates an implantable access port comprising a ball and socket bottom exit tube coupling and a coupling device according to an embodiment of the present invention.



FIG. 2B illustrates the access port and the coupling device of FIG. 2A mated together according to an embodiment of the present invention.



FIG. 2C illustrates a side cut-away view of the port and the coupling device of FIG. 2B according to an embodiment of the present invention.



FIG. 3A illustrates a perspective view of an alternative port according to an embodiment of the present invention.



FIG. 3B illustrates a perspective bottom view of the port of FIG. 3A according to an embodiment of the present invention.



FIG. 3C illustrates a side cutaway view of the port of FIG. 3A according to an embodiment of the present invention.



FIG. 3D illustrates an exploded view of the components of the port of FIG. 3A according to an embodiment of the present invention.



FIG. 4 illustrates an implantable access port comprising a side exit tube coupler according to an embodiment of the present invention.



FIG. 5A illustrates a perspective view of an implantable access port comprising a bottom exit tube coupler positioned directly in the tissue of a patient according to an embodiment of the present invention.



FIG. 5B illustrates a top perspective view of the access port of FIG. 5A according to an embodiment of the present invention.





DETAILED DESCRIPTION

The present invention relates to implantable medical devices and fasteners therefore and more specifically to access ports and methods for applying the same to bodily tissue. Specifically, the present invention is directed to a subcutaneous implantable gastric banding system including a subcutaneously attached access port coupled to bodily tissue. In some embodiments, a tube and component guard plate, a flexible exit tube coupling and/or a flexibly oriented exit tube coupling, bottom exit tube orientation and/or a tissue guard may reduce pain caused by errant needle sticks/strikes or reduce the need for follow-up surgery to repair damaged components.


In various embodiments, the present invention utilizes tube guards, component guards, tissue shields, pre-fabricated mesh and porous coupling devices and/or combinations thereof to protect the patient from unnecessary pain or discomfort. In some embodiments, a mesh material and/or coupling device (described in greater detail below) may be used to anchor an access port to a patient's tissue. For example, the mesh material may encourage tissue ingrowth or tissue engagement through holes and spaces of the mesh material. This use of mesh materials to anchor the access port using the patient's own tissue engagement may obviate the need for sutures during implantation. For example, where access port implantation may occur using sutures, during recovery and beyond, movement of the patient may cause discomfort due to a pulling and slight tearing of the tissue around the implantation site. Use of a porous coupling device or prefabricated mesh material according to embodiments of the present invention may eliminate or substantially reduce this discomfort.


In accordance with various embodiments, FIGS. 1A-1D illustrate simplified views of an access port 10 for use in conjunction with an implantable medical device, such as an implantable gastric banding system. The access port 10 may comprise a septum 15 for passing fluid into the access port 10, or removing fluid by means of the access port 10, via a needle. The access port 10 may provide a convenient means for inflating and/or deflating a conventional gastric band, thereby enabling adjustment of a size of a stoma or a level of restriction on a patient's stomach. A tube 6, coupled to or integral to the access port 10, passes the fluid from the access port 10 to and from the gastric band. The access port 10 is generally fixed within the interior of a patient's body, preferably secured to a patient's abdominal muscle.


In various embodiments, the access port 10 comprises at least one anchoring surface 8. The anchoring surface 8 may comprise any suitable anchoring surface, such as a latch, clip, hole, ridge, recess, surface deformity, notch, flange and/or the like. The housing of the access port 10 may comprise any suitable geometry, such as conical, cylindrical, square, block, and/or the like. The side wall of the housing of the access port 10 may comprise a surface transition to assist the operation of the anchoring surface 8.


With continued reference to FIG. 1B, and in accordance with various embodiments, a coupler 20 for assisting with the anchoring of the port 10 is depicted. The coupler 20 may comprise any suitable geometry. In one embodiment, the perimeter of the coupler 20 is larger than and extends away from the port 10 in a plane parallel to the bottom surface of the base of the housing of the port 10. The portion of the coupler 20 extending beyond the base of the housing may extend outwardly from and substantially circumscribe the base, or may extend only partially around the base of the port 10. The coupler 20 comprises a top surface and a bottom surface. The side surface of the coupler 20 may be any suitable shape such as curved or straight with any suitable thickness. The top surface of the coupler 20 comprises coupling agents 24 configured to attach the coupler 20 to the base of the port 10. These coupling agents 24 may be any suitable material and shape. For example, these coupling agents 24 may be glue, epoxy, welds, such as ultrasonic welding, posts, surface features, knobs, bolts, screws, barbs, clamps, clips and/or the like, and combinations thereof.


In one embodiment, as illustrated in FIG. 1B, the coupling agent 24 comprises one or more posts configured to create an interference fit with an opening of the anchoring surface 8 of the port 10. This interference fit may be a press fit, a friction fit, or a push fit. In one embodiment, the coupling agent 24 may be configured to latch onto the previously described surface transition of a side wall of the port 10 housing (not depicted). In various embodiments, the coupler 20 may be integrally molded into or as part of the base of the housing of the port 10.


Further, in an embodiment, a portion of the coupler 20 may be porous. For example, a plurality of through holes 22 may pass from the top surface to the bottom surface of the coupler 20. These through holes 22 may be configured to allow for tissue ingrowth or tissue engagement through the through holes 22 to serve as or assist with the anchoring of the port 10 with the patient. The through holes 22 may be formed in any configuration. For example, the spacing of the holes may be regular or irregular. The through holes 22 may be formed in substantially the entire surface of the coupler 20 or the through holes 22 may be located in a particular portion(s) of the coupler 20. For example, the through holes 22 may be located towards the outer perimeter of the coupler 20 leaving a portion of the surface without through holes 22 proximate the base of the port 10.


Further, in accordance with various embodiments, FIG. 1B illustrates a perspective view of the coupler 20 having a tissue shield 90. For example, the coupler 20 may comprise a first portion 91 without the through holes 22 and a second portion 92 having the through holes 22. The first portion 91 without the through holes 22 may act as a tissue guard protecting the surface underneath the first portion 91 from contact with the needle. The likelihood of errant needle sticks/strikes is proportional to the distance from the access port 10. Stated another way, as the distance away from the access port 10 increases, the likelihood of errant needle strikes decreases. Thus, in one embodiment, the second portion 92 comprising through holes 22 is located towards the exterior perimeter of the coupler 20 and the first portion 91 without the through holes 22 is located near the access port 10. In this embodiment, though it may be any suitable length, the tube guard 60 extends from the access port 10 to the outer perimeter of the coupler 20.


In one embodiment, the coupler 20 may comprise one or more flanges (not depicted) configured to support the flexing of the anchoring surface of the patient, such as the patient's abdominal wall adjacent to and coupled to the bottom surface of the coupler 20. For example, the flange 26 may be formed by forming a groove in the coupler 20. The coupler 20 may be made from any suitable material. For example, the coupler 20 may be made from an injection molded plastic material, injection molded rubber material, compression molded material, transfer molded material, over-molded plastic over mesh, and/or the like. In one embodiment, the coupler 20 may be integral to a surface, such as the bottom surface of the port 10.


Turning now to FIG. 1C, in accordance with an embodiment, the top surface of the coupler 20 is depicted as being mated with the bottom surface of the port 10. At least a portion of the coupler 20 extends beyond the bottom surface of the port 10. The coupling agents 24 are sized to create an inference fit with the anchoring surface 8 of the port 10 to facilitate connecting the coupler 20 to the port 10. The bottom surface of the coupler 20 is depicted as being mated with the top surface of a portion of the patient such as the tissue of the patient. A portion of the coupler 20 may be used as an attachment point to suture, staple, tack or otherwise fasten the access port 10 to the patient's body.


With further reference to FIG. 1C, according to an embodiment, a portion of the through holes 22 allows tissue growth up through the through holes 22 and above the top surface of the coupler 20. A portion of the through holes 22 allows tissue growth up through the through holes 22 to the bottom surface of the port 10. In one embodiment, a spacer disposed between, on, near, or integral to the coupling agents 24 creates a gap between the coupler 20 and the bottom surface of the port 10 to allow tissue growth through substantially one or more through holes 22.


In this manner, the body's own tissue may grow into the coupler 20 and act as an anchoring mechanism. This anchoring mechanism may be more comfortable for the patient post surgery than previous access port anchoring methods and techniques.


In another embodiment, a mesh material may be molded onto a biocompatible material such as injection molded plastic or a rubber coupler having the coupling agents 24. In one embodiment, the pre-fabricated mesh material may be sandwichably oriented between the access port 10 and a clip or coupler. Principles of the present disclosure may suitably be combined with design and principles for implantable ports and mesh material as disclosed in a co-pending U.S. patent application Ser. No. 12/904,422, entitled “IMPLANTABLE COUPLING DEVICE” filed on Oct. 14, 2010, the contents of which is hereby incorporated by reference in its entirety.


Turning now to FIG. 1D an exploded view of an embodiment of the present device 100 is presented. In this embodiment, the port 10 comprises a top housing section 12, a septum 15, a guard plate 30, a bottom exit tube coupling 16, a bottom housing section 14, and a coupler 20.


The top housing section 12 comprises a substantially circular side wall and a substantially ring shaped top opening. The top opening may be sized to permit suitable access to the septum surface 15. The thickness and height of the substantially circular side wall may be any suitable thickness. The interior of the top housing section 20, as shown in FIG. 1D, comprises a substantially circular smooth interior surface. This substantially circular interior surface may be shaped to mate with a surface of the bottom housing section 14, such as the exterior surface of the bottom housing section 14.


The septum 15 may be any suitable shape or dimension. In one embodiment, the thickness and diameter of the substantially circular septum 15 is sized to be secured in place by an interference fit between the top housing section 12 and the bottom housing section 14. The septum 15 may be made from any suitable material configured to be self-sealing after the puncture of a needle.


The bottom exit tube coupling 16 may be configured to be coupled to the tube 6. In this manner, the bottom exit tube coupling 16 may facilitate the transfer of fluid from the port to the tube 6. The bottom exit tube coupling 16 is oriented to couple with the tube 6 in a direction substantially normal to the bottom surface of the port 10, such as the bottom surface of the bottom housing section 14, away from the port 10. Stated another way, the connection of the port 10 to the tube 6 is downward (e.g. out the bottom of the port).


The first end of the bottom exit tube coupling 16 is shaped and sized for any suitable coupling, such as for an interference fit, with a portion of the bottom housing section 14 (as shown in FIGS. 1C and 1D). The bottom exit tube coupling 16 may be made from a relatively flexible material, such as a silicon rubber material for making a fluid tight connection with the bottom exit tube coupling 16. The second end of the bottom exit tube coupling 16 is shaped and sized for an interference fit with the end of the tube 6 (as shown in FIG. 1C). The second end may fashioned with a surface feature for securably attaching to the tube 6 or the tube 6 may be fashioned with a surface feature for securably attaching to the bottom exit tube coupling 16 or a combination thereof.


Moreover, the bottom exit tube coupling 16 may be made from a relatively flexible (non-rigid) material, such as a silicon rubber material, to provide generous strain relief to movement at the base of the port 10 and/or to aid in reducing the discomfort to the patient as compared with previous rigid tube coupling structures.


The length of the channel on the bottom exit tube coupling 16 between the bottom of the bottom housing section 14 and the connection with the tube 6 may be any suitable length. For instance, the length between the bottom of the bottom housing section 14 and the connection with the tube 6 may be about a centimeter or the length may be tens of centimeters.


As discussed above, the bottom housing section 14 is shaped to securably couple to the top housing section 12 via any suitable coupling method, such as via an interference fit or press fit, or by being clamped, adhered using adhesive, or otherwise coupled to the top housing section 12. The interior of the bottom housing section comprises a substantially ring shaped opening. The bottom surface of the septum 15 and the interior surface of the bottom housing section 14 form a partial interior vessel of the port. The bottom housing section 14 further comprises surface features for housing the guard plate 30. These surface features may include an opening for the guard plate 30 to be press fit into, where the opening is slightly smaller than the diameter of the guard plate 30 creating a tight press fit between the bottom housing section 14 and the guard plate 30. The bottom housing section 14 surface features may be raised support elements 31 to lift the guard plate 30 above a channel(s) 35 in the bottom exit tube coupling 34 and/or the bottom interior surface of the bottom housing section 14 may be fashioned into channels to allow the passage of fluid. For instance, these channels allow the passage of a fluid from the partial interior vessel of the port 10 through strategically placed openings 32 in the guard plate 30 to the bottom exit tube coupling 16 and to the tube 6.


The guard plate 30 may be secured to the bottom housing section 14 by any suitable means, such as through an interference fit. In another embodiment, the guard plate 30 may have more or fewer openings (as compared to FIG. 1D) at regular or irregular intervals in any suitable location on the guard plate 30. The guard plate 30 may be made from any suitable material for protecting device elements from needle strikes. For instance, the guard plate 30 may be made from titanium or stainless steel.


In one embodiment, the openings 32 in the guard plate 30 may be narrow, long openings sized smaller than the diameter of the needle point to reduce the likelihood of the needle becoming stuck in the opening 32. These openings 32 may be placed towards the edge of the guard plate 30 passing from the top surface of the guard plate 30 to the bottom surface of the guard plate 30. The guard plate 30 may be any suitable shape such as a flat disc shape. In other embodiments, the guard plate 30 may be shaped with a tapering bottom or other surface features or markings such as grooves or slots to position the guard plate 30 in a specified orientation.


Optionally, and with reference to FIGS. 1E and 1F, the coupler 20 may be replaced with a suture, mesh or other coupling means. For instance, the exterior of the top housing section 12 may be fashioned with surface features 18, such as suture holes, to suture the port 10 to a patient.


An implantable port device 210 according to various embodiments is depicted in FIGS. 2A-2C. In such embodiments, the implantable port device 210 comprises a top housing section 212, a septum 215, an optional guard plate (not shown), a bottom exit tube coupling 216, a bottom housing section 214, a boot 246, a top plate 245 and a coupler 220.


The interface between the first end of the bottom exit coupling 216 and the bottom housing section 214 is a fluid tight ball joint system. This ball joint system may include a rounded top section configured to sit in a mating rounded bottom opening of the bottom housing section 214 having a slight taper. In this manner the bottom exit coupling 216 may move and/or rotate without losing the fluid seal in the internal vessel.


In this embodiment, the orientation of the tube 6 and/or the position of the surrounding tissue can dictate the orientation of the bottom exit tube coupling 216. This may reduce discomfort by the patient and reduce stress and strain on the tube 6 as the patient moves. In this embodiment, the bottom exit coupling 216 may be made from any suitable material such as a rubber or a semi-rigid or rigid medical grade plastic or polymer.


A top plate 245 (as shown in FIG. 2C) may be used for securing the ball joint into position. Stated another way, the bottom exit coupling 216 ball joint may be fed through the opening in the bottom housing section 214 and then a top plate 245 may sandwichably create a sealing joint which allows for pivoting movements due to a low coefficient of friction of the mating materials. The top plate 245 may be secured to the bottom housing section 214 by any suitable means, such as by a press fit, or by being clamped, or adhered using adhesive. In some embodiments, the single opening in the ball joint bottom exit coupling 216 leading from the partial internal vessel may be replaced with one or more smaller holes which couple to the interior channel. This configuration may reduce the chance of the needle becoming stuck in the opening of the ball joint bottom exit coupling 216. In some embodiments, the ball joint of the bottom exit coupling 216 may pivot up to a 30 degree angle from a central axis in 360 degrees around the axis.


Optionally, a boot 246 may be coupled around a portion of the bottom exit coupling 216 and to the bottom exterior surface of the bottom housing section 214 to form a secondary fluid seal. The boot 246 may be coupled to the bottom exit coupling 216 by any suitable means such as a press fit. Also, the boot 246 may be coupled to the bottom housing section 214 by any suitable means, such as with a press fit and/or by being adhered. The boot 246 may be made from any suitable material, such as a flexible rubber material.


In one embodiment, a guard plate 230 may be coupled to the partial interior vessel of the port 210 to protect the internal port 210 elements from needle strikes. Optionally, the coupler 220 may be replaced with a suture, mesh or other coupling means.


Another configuration of an implantable port device 310, according to various embodiments, is depicted in FIGS. 3A-3D. In such embodiments, the implantable port device 310 comprises a top cap 352, a septum 315, an internal ring 354, one or more lock tabs 356, a guard plate 330, a molded flange 358, and a bottom cap 360. The implantable port device 310 may be a low cost option which does not require some of the press fit couplings of previously described embodiments.


The septum 315 may be inserted up, into and/or partially through the top cap 352. The internal ring 354 may be placed between the guard plate 330 and the septum 315. The molded flange 358 may be inserted down into and at least partially through the bottom cap 360. The septum 315, the internal ring 354 and the guard plate 330 may be inserted into the bottom cap 360. The septum 315 and the top cap 352 may be mated with the bottom cap 360 and other elements of port 310. One or more locking tabs 356 may be inserted into apertures to securably couple the top cap 352 to the bottom cap 360. An internal fluid seal is created by assembling the implantable port device 310 as described above.


In one embodiment, the septum 315 may be made from silicon rubber. The formed rim of the septum 315 is under compression creating a fluid tight seal after assembly is complete. The internal ring 354 holds down the guard plate 330 and aids in creating the seal against the septum 315.


In one embodiment, as shown in FIG. 3C, a slight radial interference between the guard plate 330 and the molded flange 358, plus compression by the internal ring 354, positions the guard plate 330 in place. In some embodiments, the top cap 352, the septum 315, the internal ring 354, and the bottom cap 360 comprise semi-rigid to rigid materials while the one or more locking tabs 356, the septum 315, and the molded flange 358 comprise soft flexible materials. The interference between the rigid components and the soft rubber components create a fluid seal and maintain a load on the locking tabs 356 to hold the locking tabs 356 in place over time.


The clearance between the edge of the metal plate and several locations (such as indentations 332) on the molded flange 358 allow the fluid internal to the port 310 to transfer from the internal vessel of the port 310 to the molded flange 358 through the channels 335 molded into the geometry of the molded flange 358. Additionally, structural support to lift the guard plate 330 above the channels 335 is provided by molded portions 331 in the molded flange 358. In an embodiment, the coupler 318 may be replaced with a porous coupling member, mesh or other coupling means. The molded flange 358 may be made of any suitable material for flexing, such as molded silicon rubber. Additionally, strain relief on the molded flange 358 may be increased if desired by altering the geometry of the molded flange 358.


The conduit towards the bottom of and integral to the molded flange 358 may be made from any suitable material. For instance, the molded flange 358 may be made from one or more materials such as silicon rubber. A silicon rubber conduit allows for generous strain relief at the potential flex points with no metal or rigid stem connector. The rigid stem connector may increase the joint stress at the tube 6 coupling point.


Previous ports have utilized side exiting and/or rigid tube coupling structures (as depicted in FIG. 4). These structures may be susceptible to strain and/or needle puncture. Moreover, these side exiting tube 6 coupling structures often utilize an eventual turn of the tube 6 from the relatively horizontal direction to a relatively vertical position depending on the implantation point of the port. This places the tube 6 under stress and under strain at the point of change in direction. Additionally, if these side exiting ports are not suitably secured to the tissue of the patient, they may become misaligned. The flexible down stream tube 6 inserted in the patient may not provide support for the unsecured side exiting ports. For instance, an improperly secured side exit port may flip partially over or become inverted (as depicted by the arrow in FIG. 4). A partially flipped or inverted port may be unsuitable for fluid transfer via needle and/or require a surgical procedure to re-orient the device. For instance, the septum surface may be inaccessible by a needle.


The bottom exit tube coupling 358 orientation in the downward direction (relative to the base of the port 310) reduces the stress and strain placed on the tube 6 by reducing the need to bend the tube 6 from the relatively horizontal direction to the relatively horizontal direction as compared with a side exiting tube coupling. Also, the orientation of the bottom exit tube coupling 358 naturally protects the tube 6 from needle puncture. In this manner, the body of the implantable port 310 and the direction of needle insertion substantially in line with the bottom exit tube coupling 358 may protect the needle from puncture. Additionally, the physical structure of the bottom exit tube coupling 358, which exits via the base of the port 310 substantially inline with the needle insertion direction, stabilizes the position of the port 310. This physical structure (i.e., a bottom exit port coupling 358 as shown in FIGS. 5A and 5B) reduces the likelihood that the port 310 will become misaligned and/or partially flip or invert. In some embodiments, a bottom exiting port coupling will physically not be able to flip after insertion in the tissue of the patient. In this manner, the bottom exit port coupling 358 functions as an anchor and/or partial anchor of the device in a pre-selected orientation and/or position. This may also orient the implantable port 310 in a position where the septum is easily targeted by an approaching needle. In some embodiments, the exterior surface of the bottom exit coupler 358 may be altered to comprise surface features for securing and or orienting the port 310. For instance, in an embodiment, the exterior surface of the bottom exit coupler 358 may be barbed.


In one embodiment, the elements of the implantable port and/or coupler may be coated with a bioresorbable material, for example, to encourage biological compatibility between the device elements and the body tissue. The coating may cover the entirety of the device elements or only a portion of the device elements. A thickness of the coating may be even, or may vary along the surface of the device elements. The coating may be deposited through a process including a spraying process, dipping process, molding process, wiping process, or other equivalent means of attaching the bioresorbable material to the device elements. The coating thickness may vary between approximately 0.001 inches and 0.25 inches. The bioresorbable material serves to form a biological seal between the access port 10 and the body tissue, and to encourage compatibility between the access port 10 and the body tissue.


The implantable ports described herein may comprise any suitable shape. For instance, the ports may be generally conical, cylindrical, cubical, rectangular prism, or irregularly shaped. In this manner, the ports may comprise substantially circular side walls or non-circular side walls. Also, the ports may comprise top and bottom surfaces with any suitable geometric or non-geometric shape.


The terms “a,” “an,” “the” and similar referents used in the context of describing the invention (especially in the context of the following claims) are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context. Recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g., “such as”) provided herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.


Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member may be referred to and claimed individually or in any combination with other members of the group or other elements found herein. It is anticipated that one or more members of a group may be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is deemed to contain the group as modified thus fulfilling the written description of all Markush groups used in the appended claims.


Certain embodiments of this invention are described herein, including the best mode known to the inventors for carrying out the invention. Of course, variations on these described embodiments will become apparent to those of ordinary skill in the art upon reading the foregoing description. The inventor expects skilled artisans to employ such variations as appropriate, and the inventors intend for the invention to be practiced otherwise than specifically described herein. Accordingly, this invention includes all modifications and equivalents of the subject matter recited in the claims appended hereto as permitted by applicable law. Moreover, any combination of the above-described elements in all possible variations thereof is encompassed by the invention unless otherwise indicated herein or otherwise clearly contradicted by context.


Specific embodiments disclosed herein may be further limited in the claims using “consisting of” or “consisting essentially of” language. When used in the claims, whether as filed or added per amendment, the transition term “consisting of” excludes any element, step, or ingredient not specified in the claims. The transition term “consisting essentially of” limits the scope of a claim to the specified materials or steps and those that do not materially affect the basic and novel characteristic(s). Embodiments of the invention so claimed are inherently or expressly described and enabled herein.


In closing, it is to be understood that the embodiments of the invention disclosed herein are illustrative of the principles of the present invention. Other modifications that may be employed are within the scope of the invention. Thus, by way of example, but not of limitation, alternative configurations of the present invention may be utilized in accordance with the teachings herein. Accordingly, the present invention is not limited to that precisely as shown and described.

Claims
  • 1. An implantable access port for use with a gastric band for the treatment of obesity, the implantable access port comprising: a septum surface;a top housing section comprising a top opening for the septum surface;a bottom exit tube coupling that provides a partial anchoring of the implantable access port in a pre-selected position;a bottom housing section, wherein a partial interior vessel is formed by a fluid seal created between a bottom surface of the septum surface and an interior surface of the bottom housing section; anda porous coupling member having a top surface and a bottom surface, said porous coupling member having a first portion extending substantially parallel to a base of the bottom housing section, wherein the first portion does not comprise a porous surface and a second portion extending substantially parallel to the base of the bottom housing section, wherein the second portion comprises a porous surface, and wherein the first portion is configured to shield a portion of a patient from contact with a needle.
  • 2. The implantable access port of claim 1, wherein the implantable port is configured to shield a coupled tube from inadvertent needle puncture using at least one of an orientation of the bottom exit tube coupling, needle entry orientation, or structures of a body of the implantable port.
  • 3. The implantable access port of claim 1, wherein the porous coupling member is at least one of integral to the implantable access port or coupled to the implantable access port via a coupling agent proximate the top surface of the porous coupling member for mating with the base of the implantable access port.
  • 4. The implantable access port of claim 1, wherein the porous coupling member extends substantially parallel to the base of the bottom housing section, and wherein the bottom surface of the porous coupling member is configured for anchoring the porous coupling member to a tissue of a patient.
  • 5. The implantable access port of claim 1, wherein the porous coupling member is made from injection moldable plastic or rubber.
  • 6. The implantable access port of claim 1, wherein the porous coupling member is at least one of a partial ring shape or a substantially circular shape.
  • 7. The implantable access port of claim 1, wherein the first portion is proximate to the implantable access port.
  • 8. The implantable access port of claim 1, wherein the bottom housing section further comprises surface features for at least one of positioning a guard plate or channeling fluid from the partial interior vessel to the bottom exit tube coupling.
  • 9. The implantable access port of claim 1, wherein the top housing section and the bottom housing section couple together to place the septum surface under compression.
  • 10. The implantable access port of claim 9, wherein the top housing section and the bottom housing section are securably coupled together via lock tabs.
  • 11. An implantable access port for use with a gastric band for the treatment of obesity, the implantable access port comprising: a septum surface;a top housing section comprising a top opening for the septum surface;a bottom exit tube coupling that provides a partial anchoring of the implantable access port in a pre-selected position;a bottom housing section, wherein a partial interior vessel is formed by a fluid seal created between a bottom surface of the septum surface and an interior surface of the bottom housing section;a mesh material oriented between the implantable access port and a coupling member; anda through hole in the mesh material configured to allow the coupling member to pass through the through hole to mate with a base of the implantable access port.
  • 12. The implantable access port of claim 11, wherein the mesh material is a pre-fabricated mesh material made from injection moldable plastic or rubber.
  • 13. The implantable access port of claim 11, wherein the port is configured to be implanted subcutaneously.
  • 14. A method of securably coupling to a tissue of a patient an implantable access port of an adjustable gastric banding system configured to facilitate fluid transfer to and from the gastric banding system, the method comprising: subcutaneously coupling an implantable fluid access port having a bottom exit tube coupling to the tissue of the patient, the bottom exit tube coupling made from a silicon rubber material and is configured to provide a partial anchoring of the implantable access port in a pre-selected position, wherein the port comprises a septum configured to receive a needle for fluid transfer; andcoupling a tube of the adjustable gastric banding system to the bottom exit tube coupling.
  • 15. The method of claim 14, further comprising protecting the bottom exit tube coupling via a guard plate internal to the port.
  • 16. The method of claim 14, wherein the subcutaneous coupling is performed via at least one of a mesh material oriented between the implantable access port and a coupling member, sutures, or a porous coupler.
  • 17. An implantable access port for use with a gastric band for the treatment of obesity, the implantable access port comprising: a septum surface;a top housing section comprising a top opening for the septum surface;a bottom exit tube coupling that provides a partial anchoring of the implantable access port in a pre-selected position;
  • 18. The implantable access port of claim 17, wherein the guard plate is internal to the partial interior vessel.
  • 19. An implantable access port for use with a gastric band for the treatment of obesity, the implantable access port comprising: a septum surface;a top housing section comprising a top opening for the septum surface;a bottom exit tube coupling comprising a ball joint socket that provides a partial anchoring of the implantable access port in a pre-selected position; anda bottom housing section, wherein a partial interior vessel is formed by a fluid seal created between a bottom surface of the septum surface and an interior surface of the bottom housing section.
  • 20. The implantable access port of claim 19, wherein the bottom exit tube coupling further comprises a rubber boot.
  • 21. An implantable access port for use with a gastric band for the treatment of obesity, the implantable access port comprising: a septum surface;a top housing section comprising a top opening for the septum surface;a bottom exit tube coupling made from a silicon rubber material wherein the bottom exit tube coupling is configured to provide a partial anchoring of the implantable access port in a pre-selected position; anda bottom housing section, wherein a partial interior vessel is formed by a fluid seal created between a bottom surface of the septum surface and an interior surface of the bottom housing section.
  • 22. A method of securably coupling to a tissue of a patient an implantable access port of an adjustable gastric banding system configured to facilitate fluid transfer to and from the gastric banding system, the method comprising: subcutaneously coupling an implantable fluid access port having a bottom exit tube coupling to the tissue of the patient, wherein the port comprises a septum configured to receive a needle for fluid transfer, wherein the subcutaneous coupling is performed via at least one of a mesh material oriented between the implantable access port and a coupling member, sutures, or a porous coupler; andcoupling a tube of the adjustable gastric banding system to the bottom exit tube coupling.
  • 23. A method of securably coupling to a tissue of a patient an implantable access port of an adjustable gastric banding system configured to facilitate fluid transfer to and from the gastric banding system, the method comprising: subcutaneously coupling an implantable fluid access port having a bottom exit tube coupling to the tissue of the patient, wherein the port comprises a septum configured to receive a needle for fluid transfer;protecting the bottom exit tube coupling via a guard plate internal to the port; andcoupling a tube of the adjustable gastric banding system to the bottom exit tube coupling.
RELATED APPLICATIONS

This application is a continuation-in-part of, and claims priority to and the benefit of U.S. patent application Ser. No. 12/904,422, entitled “IMPLANTABLE COUPLING DEVICE” filed on Oct. 14, 2010, which is a continuation-in-part of U.S. patent application Ser. No. 12/772,039, entitled “SYSTEM INCLUDING ACCESS PORT AND APPLICATOR TOOL” filed on Apr. 30, 2010, which claims priority to and the benefit of U.S. Provisional patent application No. 61/237,641, filed on Aug. 27, 2009, and U.S. Provisional patent application No. 61/236,869, filed on Aug. 26, 2009, all of these applications are hereby expressly incorporated by reference herein.

US Referenced Citations (424)
Number Name Date Kind
586113 Bott Jul 1897 A
2163048 McKee Jun 1939 A
2737954 Knapp Mar 1956 A
3371352 Siposs et al. Mar 1968 A
3569660 Houldcroft Mar 1971 A
3587115 Shiley Jun 1971 A
3596660 Melone Aug 1971 A
3667081 Burger Jun 1972 A
3688764 Reed Sep 1972 A
3840018 Heifetz Oct 1974 A
3958562 Hakim et al. May 1976 A
3971376 Wichterle Jul 1976 A
4019499 Fitzgerald Apr 1977 A
4118805 Reimels Oct 1978 A
4151835 Showell et al. May 1979 A
4161943 Nogier Jul 1979 A
4164943 Hill et al. Aug 1979 A
4190040 Schulte Feb 1980 A
4233992 Bisping Nov 1980 A
4265252 Chubbuck et al. May 1981 A
4280722 Guptil et al. Jul 1981 A
4413985 Wellner Nov 1983 A
4474572 McNaughton et al. Oct 1984 A
4502335 Wamstad et al. Mar 1985 A
4543088 Bootman et al. Sep 1985 A
4557722 Harris Dec 1985 A
4569675 Prosl et al. Feb 1986 A
4588394 Schulte et al. May 1986 A
4592339 Kuzmak et al. Jun 1986 A
4592355 Antebi Jun 1986 A
4634427 Hannula et al. Jan 1987 A
4655765 Swift Apr 1987 A
4673394 Fenton, Jr. et al. Jun 1987 A
4692146 Hilger Sep 1987 A
4696288 Kuzmak et al. Sep 1987 A
4704103 Stober et al. Nov 1987 A
4710174 Moden et al. Dec 1987 A
4738657 Hancock et al. Apr 1988 A
4767410 Moden et al. Aug 1988 A
4772270 Wiita et al. Sep 1988 A
4778452 Moden et al. Oct 1988 A
4781680 Redmond et al. Nov 1988 A
4796641 Mills et al. Jan 1989 A
4802885 Weeks et al. Feb 1989 A
4832054 Bark May 1989 A
4840615 Hancock et al. Jun 1989 A
4850227 Luettgen et al. Jul 1989 A
4858623 Bradshaw et al. Aug 1989 A
4861341 Woodburn Aug 1989 A
4881939 Newman Nov 1989 A
4886501 Johnston et al. Dec 1989 A
4902278 Maget et al. Feb 1990 A
4904241 Bark Feb 1990 A
4913702 Yum et al. Apr 1990 A
4915690 Cone et al. Apr 1990 A
4929230 Pfleger May 1990 A
4929236 Sampson May 1990 A
4966588 Rayman et al. Oct 1990 A
4967755 Pohndorf Nov 1990 A
4978338 Melsky et al. Dec 1990 A
5006115 McDonald Apr 1991 A
5013298 Moden et al. May 1991 A
5026344 Dijkstra et al. Jun 1991 A
5041098 Loiterman et al. Aug 1991 A
5045060 Melsky et al. Sep 1991 A
5074868 Kuzmak Dec 1991 A
5090954 Geary Feb 1992 A
5092897 Forte Mar 1992 A
5094244 Callahan et al. Mar 1992 A
5098397 Svensson Mar 1992 A
5108377 Cone et al. Apr 1992 A
5125408 Basser Jun 1992 A
5133753 Bark et al. Jul 1992 A
5137529 Watson et al. Aug 1992 A
5147483 Melsky et al. Sep 1992 A
5152747 Olivier Oct 1992 A
5167638 Felix et al. Dec 1992 A
5185003 Brethauer Feb 1993 A
5207644 Strecker May 1993 A
5213574 Tucker May 1993 A
5226429 Kuzmak Jul 1993 A
5226894 Haber et al. Jul 1993 A
5250026 Ehrlich et al. Oct 1993 A
5273537 Haskvitz et al. Dec 1993 A
5281205 McPherson Jan 1994 A
5284479 de Jong Feb 1994 A
5318545 Tucker Jun 1994 A
5336194 Polaschegg et al. Aug 1994 A
5337747 Neftel Aug 1994 A
5360407 Leonard et al. Nov 1994 A
5368040 Carney Nov 1994 A
5387192 Glantz et al. Feb 1995 A
5391164 Giampapa Feb 1995 A
5449368 Kuzmak Sep 1995 A
5476460 Montalvo Dec 1995 A
5514174 Heil, Jr. et al. May 1996 A
5540648 Yoon Jul 1996 A
5556388 Johlin, Jr. Sep 1996 A
5558641 Glantz et al. Sep 1996 A
5562617 Finch, Jr. et al. Oct 1996 A
5571104 Li Nov 1996 A
5575777 Cover et al. Nov 1996 A
5601604 Vincent Feb 1997 A
5637102 Tolkoff et al. Jun 1997 A
5653755 Ledergerber Aug 1997 A
5658298 Vincent et al. Aug 1997 A
5674397 Pawlak et al. Oct 1997 A
5683447 Bush et al. Nov 1997 A
5688237 Rozga et al. Nov 1997 A
5695490 Flaherty et al. Dec 1997 A
5716342 Dumbraveanu et al. Feb 1998 A
5718682 Tucker Feb 1998 A
5722957 Steinbach Mar 1998 A
5748200 Funahashi May 1998 A
5810735 Halperin et al. Sep 1998 A
5814019 Steinbach et al. Sep 1998 A
5833654 Powers et al. Nov 1998 A
5843033 Ropiak Dec 1998 A
RE36176 Kuzmak Mar 1999 E
5883654 Katsuyama Mar 1999 A
5902598 Chen et al. May 1999 A
5906596 Tallarida May 1999 A
5910149 Kuzmak Jun 1999 A
5911704 Humes Jun 1999 A
5931829 Burbank et al. Aug 1999 A
5932460 Mills et al. Aug 1999 A
5935083 Williams Aug 1999 A
5938669 Klaiber et al. Aug 1999 A
5951512 Dalton Sep 1999 A
6024704 Meador et al. Feb 2000 A
6030369 Engelson et al. Feb 2000 A
6039712 Fogarty et al. Mar 2000 A
6074341 Anderson et al. Jun 2000 A
6090066 Schnell Jul 2000 A
6098405 Miyata et al. Aug 2000 A
6102678 Peclat Aug 2000 A
6102922 Jakobsson et al. Aug 2000 A
6123700 Mills et al. Sep 2000 A
6152885 Taepke Nov 2000 A
6171252 Roberts Jan 2001 B1
6183449 Sibbitt Feb 2001 B1
6213973 Eliasen et al. Apr 2001 B1
6221024 Miesel Apr 2001 B1
6234973 Meador et al. May 2001 B1
6258079 Burbank et al. Jul 2001 B1
6264676 Gellman et al. Jul 2001 B1
6270475 Bestetti Aug 2001 B1
6283949 Roorda Sep 2001 B1
6321124 Cigaina Nov 2001 B1
6349740 Cho et al. Feb 2002 B1
6432040 Meah Aug 2002 B1
6450946 Forsell Sep 2002 B1
6453907 Forsell Sep 2002 B1
6454699 Forsell Sep 2002 B1
6459917 Gowda et al. Oct 2002 B1
6461293 Forsell Oct 2002 B1
6464628 Forsell Oct 2002 B1
6470213 Alley Oct 2002 B1
6470892 Forsell Oct 2002 B1
6478783 Moorehead Nov 2002 B1
6511490 Robert Jan 2003 B2
6547801 Dargent et al. Apr 2003 B1
6572587 Lerman et al. Jun 2003 B2
6589184 Noren et al. Jul 2003 B2
6648849 Tenhuisen et al. Nov 2003 B2
6666845 Hooper et al. Dec 2003 B2
6689100 Connelly et al. Feb 2004 B2
6723053 Ackerman et al. Apr 2004 B2
6733519 Lashinski et al. May 2004 B2
6792309 Noren Sep 2004 B1
6810880 Jennings, Jr. et al. Nov 2004 B1
6813964 Clark et al. Nov 2004 B1
6860857 Noren et al. Mar 2005 B2
6915162 Noren et al. Jul 2005 B2
6921267 van Oostrom et al. Jul 2005 B2
6929631 Brugger et al. Aug 2005 B1
6939299 Petersen et al. Sep 2005 B1
6953444 Rosenberg Oct 2005 B2
6964204 Clark et al. Nov 2005 B2
6966875 Longobardi Nov 2005 B1
6997914 Smith et al. Feb 2006 B2
7017583 Forsell Mar 2006 B2
7020531 Colliou et al. Mar 2006 B1
7056286 Ravenscroft et al. Jun 2006 B2
7063669 Brawner et al. Jun 2006 B2
7073387 Zdeblick et al. Jul 2006 B2
7082843 Clark et al. Aug 2006 B2
7131945 Fink et al. Nov 2006 B2
7144400 Byrum et al. Dec 2006 B2
7149587 Wardle et al. Dec 2006 B2
7191007 Desai et al. Mar 2007 B2
7195774 Carvalho et al. Mar 2007 B2
7223239 Schulze May 2007 B2
7226419 Lane et al. Jun 2007 B2
7261003 McDonald et al. Aug 2007 B2
7267645 Anderson et al. Sep 2007 B2
7282023 Frering Oct 2007 B2
7311716 Byrum Dec 2007 B2
7311717 Egle Dec 2007 B2
7351198 Byrum et al. Apr 2008 B2
7351226 Herskowitz Apr 2008 B1
7351240 Hassler, Jr. et al. Apr 2008 B2
7353747 Swayze et al. Apr 2008 B2
7364542 Jambor et al. Apr 2008 B2
7367937 Jambor et al. May 2008 B2
7374557 Conlon May 2008 B2
7374565 Hassler, Jr. et al. May 2008 B2
7390294 Hassler, Jr. Jun 2008 B2
7413547 Lichtscheidl et al. Aug 2008 B1
7416528 Crawford et al. Aug 2008 B2
7437951 McDonald et al. Oct 2008 B2
7438718 Milliman et al. Oct 2008 B2
7445614 Bunodiere et al. Nov 2008 B2
7468038 Ye et al. Dec 2008 B2
7500944 Byrum et al. Mar 2009 B2
7510530 Hashimoto et al. Mar 2009 B2
7530943 Lechner May 2009 B2
7553298 Hunt Jun 2009 B2
7561916 Hunt Jul 2009 B2
7580746 Gilkerson et al. Aug 2009 B2
7591185 Mothilal et al. Sep 2009 B1
7593777 Gerber Sep 2009 B2
7634319 Schneider et al. Dec 2009 B2
7651483 Byrum Jan 2010 B2
7658196 Ferreri et al. Feb 2010 B2
7699770 Hassler, Jr. et al. Apr 2010 B2
7708722 Glenn May 2010 B2
7762998 Birk et al. Jul 2010 B2
7762999 Byrum Jul 2010 B2
7775215 Hassler, Jr. et al. Aug 2010 B2
7775966 Dlugos et al. Aug 2010 B2
7811275 Birk et al. Oct 2010 B2
7850660 Uth et al. Dec 2010 B2
7862546 Conlon et al. Jan 2011 B2
7909754 Hassler, Jr. et al. Mar 2011 B2
7909804 Stats Mar 2011 B2
8007474 Uth et al. Aug 2011 B2
20010052141 Andersen Dec 2001 A1
20020013545 Soltanpour et al. Jan 2002 A1
20020058969 Noren et al. May 2002 A1
20020087147 Hooper et al. Jul 2002 A1
20020095181 Beyer Jul 2002 A1
20020139208 Yatskov Oct 2002 A1
20020198548 Robert Dec 2002 A1
20030045800 Noren et al. Mar 2003 A1
20030045910 Sorensen et al. Mar 2003 A1
20030073880 Polsky et al. Apr 2003 A1
20030078506 Noren et al. Apr 2003 A1
20030139690 Aebli et al. Jul 2003 A1
20040064110 Forsell Apr 2004 A1
20040065615 Hooper et al. Apr 2004 A1
20040068233 DiMatteo Apr 2004 A1
20040082908 Whitehurst et al. Apr 2004 A1
20040111050 Smedley et al. Jun 2004 A1
20040204692 Eliasen Oct 2004 A1
20040254536 Conlon et al. Dec 2004 A1
20040254537 Conlon Dec 2004 A1
20040260229 Meir Dec 2004 A1
20040260319 Egle Dec 2004 A1
20040267288 Byrum et al. Dec 2004 A1
20040267291 Byrum et al. Dec 2004 A1
20040267292 Byrum et al. Dec 2004 A1
20040267293 Byrum et al. Dec 2004 A1
20040267377 Egle Dec 2004 A1
20050010177 Tsai Jan 2005 A1
20050049578 Tu et al. Mar 2005 A1
20050070875 Kulessa Mar 2005 A1
20050070937 Jambor et al. Mar 2005 A1
20050085778 Parks Apr 2005 A1
20050092093 Kang et al. May 2005 A1
20050131325 Chen et al. Jun 2005 A1
20050131352 Conlon Jun 2005 A1
20050131383 Chen et al. Jun 2005 A1
20050148956 Conlon Jul 2005 A1
20050149143 Libbus et al. Jul 2005 A1
20050209573 Brugger et al. Sep 2005 A1
20050240155 Conlon Oct 2005 A1
20050240156 Conlon Oct 2005 A1
20050267500 Hassler, Jr. et al. Dec 2005 A1
20050277899 Conlon Dec 2005 A1
20050283041 Egle Dec 2005 A1
20050283118 Uth et al. Dec 2005 A1
20050283119 Uth Dec 2005 A1
20060074439 Garner et al. Apr 2006 A1
20060122578 Lord et al. Jun 2006 A1
20060161186 Hassler, Jr. et al. Jul 2006 A1
20060173423 Conlon Aug 2006 A1
20060173424 Conlon Aug 2006 A1
20060178647 Stats Aug 2006 A1
20060178648 Barron et al. Aug 2006 A1
20060184141 Smith et al. Aug 2006 A1
20060189887 Hassler, Jr. et al. Aug 2006 A1
20060189888 Hassler, Jr. et al. Aug 2006 A1
20060190039 Birk Aug 2006 A1
20060199997 Hassler, Jr. et al. Sep 2006 A1
20060211912 Dlugos et al. Sep 2006 A1
20060211913 Dlugos et al. Sep 2006 A1
20060211914 Hassler, Jr. et al. Sep 2006 A1
20060217668 Schulze et al. Sep 2006 A1
20060217673 Schulze et al. Sep 2006 A1
20060235445 Birk Oct 2006 A1
20060235448 Roslin et al. Oct 2006 A1
20060247539 Schugt et al. Nov 2006 A1
20060266128 Clark et al. Nov 2006 A1
20060293625 Hunt et al. Dec 2006 A1
20060293626 Byrum et al. Dec 2006 A1
20060293627 Byrum Dec 2006 A1
20060293628 Hunt et al. Dec 2006 A1
20070010790 Byrum et al. Jan 2007 A1
20070015954 Dlugos Jan 2007 A1
20070015955 Tsonton Jan 2007 A1
20070016231 Jambor et al. Jan 2007 A1
20070027356 Ortiz Feb 2007 A1
20070038255 Kieval et al. Feb 2007 A1
20070060959 Salo et al. Mar 2007 A1
20070073250 Schneiter Mar 2007 A1
20070078391 Wortley Apr 2007 A1
20070088336 Dalton Apr 2007 A1
20070088391 McAlexander Apr 2007 A1
20070129765 Gilkerson et al. Jun 2007 A1
20070135758 Childers et al. Jun 2007 A1
20070149947 Byrum Jun 2007 A1
20070156013 Birk Jul 2007 A1
20070158769 You Jul 2007 A1
20070161958 Glenn Jul 2007 A1
20070167672 Dlugos et al. Jul 2007 A1
20070173685 Jambor et al. Jul 2007 A1
20070185462 Byrum Aug 2007 A1
20070191717 Rosen et al. Aug 2007 A1
20070205384 Kurosawa Sep 2007 A1
20070208313 Conlon Sep 2007 A1
20070213837 Ferreri et al. Sep 2007 A1
20070219510 Zinn et al. Sep 2007 A1
20070235083 Dlugos Oct 2007 A1
20070250086 Wiley et al. Oct 2007 A1
20070255165 Uesugi et al. Nov 2007 A1
20070255234 Haase et al. Nov 2007 A1
20070265666 Roberts et al. Nov 2007 A1
20070282196 Birk et al. Dec 2007 A1
20070293829 Conlon et al. Dec 2007 A1
20080009680 Hassler, Jr. Jan 2008 A1
20080015406 Dlugos et al. Jan 2008 A1
20080039772 Chantriaux et al. Feb 2008 A1
20080058632 Tai et al. Mar 2008 A1
20080097496 Chang et al. Apr 2008 A1
20080114308 di Palma et al. May 2008 A1
20080119798 Chantriaux et al. May 2008 A1
20080243093 Kalpin et al. Oct 2008 A1
20080249806 Dlugos et al. Oct 2008 A1
20080250340 Dlugos et al. Oct 2008 A1
20080250341 Dlugos et al. Oct 2008 A1
20080255403 Voegele et al. Oct 2008 A1
20080255414 Voegele et al. Oct 2008 A1
20080255425 Voegele et al. Oct 2008 A1
20080255459 Voegele et al. Oct 2008 A1
20080255537 Voegele et al. Oct 2008 A1
20080281412 Smith et al. Nov 2008 A1
20080287969 Tsonton et al. Nov 2008 A1
20080287974 Widenhouse et al. Nov 2008 A1
20080312553 Timmons Dec 2008 A1
20080319435 Rioux et al. Dec 2008 A1
20090018608 Schwartz et al. Jan 2009 A1
20090048524 Wildau et al. Feb 2009 A1
20090054914 Lechner Feb 2009 A1
20090062825 Pool et al. Mar 2009 A1
20090071258 Kouda et al. Mar 2009 A1
20090076466 Quebbemann et al. Mar 2009 A1
20090082757 Rogers et al. Mar 2009 A1
20090082793 Birk Mar 2009 A1
20090093768 Conlon et al. Apr 2009 A1
20090099538 Paganon Apr 2009 A1
20090105735 Stam et al. Apr 2009 A1
20090112308 Kassem Apr 2009 A1
20090118572 Lechner May 2009 A1
20090149874 Ortiz et al. Jun 2009 A1
20090157106 Marcotte Jun 2009 A1
20090157107 Kierath et al. Jun 2009 A1
20090157113 Marcotte et al. Jun 2009 A1
20090171375 Coe et al. Jul 2009 A1
20090171378 Coe et al. Jul 2009 A1
20090171379 Coe et al. Jul 2009 A1
20090192404 Ortiz et al. Jul 2009 A1
20090192415 Ortiz et al. Jul 2009 A1
20090192533 Dlugos, Jr. et al. Jul 2009 A1
20090192534 Ortiz et al. Jul 2009 A1
20090192541 Ortiz et al. Jul 2009 A1
20090198261 Schweikert Aug 2009 A1
20090202387 Dlugos, Jr. et al. Aug 2009 A1
20090204131 Ortiz et al. Aug 2009 A1
20090204132 Ortiz et al. Aug 2009 A1
20090209995 Byrum et al. Aug 2009 A1
20090216255 Coe et al. Aug 2009 A1
20090221974 Paganon Sep 2009 A1
20090222031 Axelsson Sep 2009 A1
20090222065 Dlugos, Jr. et al. Sep 2009 A1
20090227862 Smith et al. Sep 2009 A1
20090228028 Coe Sep 2009 A1
20090228072 Coe et al. Sep 2009 A1
20090248125 Brostrom Oct 2009 A1
20090248126 Nippoldt et al. Oct 2009 A1
20090254052 Birk et al. Oct 2009 A1
20090259190 Birk et al. Oct 2009 A1
20090259191 Birk et al. Oct 2009 A1
20090259231 Birk et al. Oct 2009 A1
20090264901 Franklin Oct 2009 A1
20090270904 Birk et al. Oct 2009 A1
20090299216 Chen et al. Dec 2009 A1
20090299672 Zhang et al. Dec 2009 A1
20090306462 Lechner Dec 2009 A1
20090308169 Mothilal et al. Dec 2009 A1
20100087843 Bertolote et al. Apr 2010 A1
20100100079 Berkcan et al. Apr 2010 A1
20100114149 Albrecht et al. May 2010 A1
20100130941 Conlon et al. May 2010 A1
20100152532 Marcotte Jun 2010 A1
20100191271 Lau et al. Jul 2010 A1
20100211085 Uth et al. Aug 2010 A1
20100217198 Franklin et al. Aug 2010 A1
20100217199 Uth et al. Aug 2010 A1
20100217200 Uth et al. Aug 2010 A1
20100228080 Tavori et al. Sep 2010 A1
20100234808 Uth et al. Sep 2010 A1
20110054407 Olroyd et al. Mar 2011 A1
20110082426 Conlon et al. Apr 2011 A1
Foreign Referenced Citations (59)
Number Date Country
1250382 Apr 2000 CN
1367670 Sep 2002 CN
3927001 Feb 1991 DE
4211045 Oct 1993 DE
19751791 May 1997 DE
19745654 Apr 1999 DE
0343910 Nov 1989 EP
0611561 Sep 1993 EP
0858814 Aug 1998 EP
0867197 Sep 1998 EP
1057457 Dec 2000 EP
1346753 Sep 2003 EP
1396242 Mar 2004 EP
1396243 Mar 2004 EP
1488824 Dec 2004 EP
1543861 Jun 2005 EP
1547643 Jun 2005 EP
1591140 Nov 2005 EP
1736194 Dec 2006 EP
1736195 Dec 2006 EP
1736196 Dec 2006 EP
1736197 Dec 2006 EP
1736198 Dec 2006 EP
1736199 Dec 2006 EP
1870126 Dec 2007 EP
1985263 Oct 2008 EP
2070494 Jun 2009 EP
2095798 Sep 2009 EP
2740977 May 1997 FR
2797181 Feb 2001 FR
2823663 Oct 2002 FR
2851168 Aug 2004 FR
2855744 Dec 2004 FR
2916980 Dec 2008 FR
2119877 May 1990 JP
8107934 Apr 1996 JP
1823791 Jun 1991 SU
WO 9220519 Nov 1992 WO
WO 9422520 Oct 1994 WO
WO 9640357 Dec 1996 WO
WO 9701370 Jan 1997 WO
WO 9920338 Apr 1999 WO
WO 9926543 Jun 1999 WO
WO 9934859 Jul 1999 WO
WO 0015158 Mar 2000 WO
WO 0033901 Jun 2000 WO
WO 0110359 Feb 2001 WO
WO 0149245 Jul 2001 WO
WO 0180926 Nov 2001 WO
WO 0195813 Dec 2001 WO
WO 0210667 Feb 2002 WO
WO 02074381 Sep 2002 WO
WO 03105732 Dec 2003 WO
WO 2004016971 Mar 2004 WO
WO 2005037055 Apr 2005 WO
WO 2005072627 Aug 2005 WO
WO 2006021695 Mar 2006 WO
WO 2009007526 Jan 2009 WO
WO 2009129474 Oct 2009 WO
Non-Patent Literature Citations (6)
Entry
Helioscopie Product Insert for Heliogast, pp. 1-11 (undated).
Autumn K. et al.; “Evidence of Van Der Waals Adhesion in Gecko Setae”; PNAS; vol. 99; No. 19; pp. 12252-12256; Sep. 17, 2012.
Geim AK. et al.; “Microfabricated Adhesive Mimicking Gecko Foot-Hair”; Nature Materials Abstract only; vol. 2; No. 7; 2003.
Yamagami, Takuji; “Technical Developments: Use of Targeting Guide Wire in Left Subclavian Puncture During Percutaneous Implantation of Port-Catheter Systems Using the Catheter Tip Fixation Method” European Radiology; vol. 13; pp. 863-866; 2003.
Yurdumakan B., et al.; “Synthetic Gecko Foot-Hairs from Multiwalled Carbon Nanotubes”; The Royal Society of Chemistry; p. 3799-3801; 2005.
http://en/wikipedia.org/Injection—Molding, Accessed Sep. 6, 2012.
Related Publications (1)
Number Date Country
20110218392 A1 Sep 2011 US
Provisional Applications (2)
Number Date Country
61237641 Aug 2009 US
61236869 Aug 2009 US
Continuation in Parts (2)
Number Date Country
Parent 12904422 Oct 2010 US
Child 13021099 US
Parent 12772039 Apr 2010 US
Child 12904422 US